Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Willis S. Bowman"'
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) is the prototypical progressive fibrosing ILD (PF-ILD), a high
Externí odkaz:
https://doaj.org/article/b61b622ae8c44999ae870929da5db12c
Autor:
Chad A. Newton, Justin M. Oldham, Christine Kim Garcia, Claire Cutting, Willis S. Bowman, Janelle Vu Pugashetti, Nam Dao
Publikováno v:
Chest. 159:1913-1921
A number of genetic markers linked to familial pulmonary fibrosis predict differential survival in interstitial lung disease (ILD) patients. Although genetic testing is not performed routinely for ILD, family history commonly is obtained and may info
Autor:
Willis S. Bowman, Timothy Dempsey
Publikováno v:
Annals of the American Thoracic Society. 19(7)
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 8 (2021)
Frontiers in Medicine, Vol 8 (2021)
Interstitial lung disease (ILD) comprises a heterogenous group of diffuse lung disorders that commonly result in irreversible pulmonary fibrosis. While idiopathic pulmonary fibrosis (IPF) is the prototypical progressive fibrosing ILD (PF-ILD), a high
Autor:
Mary E. Strek, Janelle Vu Pugashetti, Imre Noth, Angela L. Linderholm, Ayodeji Adegunsoye, Anne I. Sperling, Willis S. Bowman, Justin M. Oldham, Cathryn Lee, Nandini Sarma, Shwu Fan Ma, Angela Franciska Haczku, Shehabaldin Alqalyoobi
Publikováno v:
Chest, vol 158, iss 4
BackgroundA number of circulating plasma biomarkers have been shown to predict survival in patients with idiopathic pulmonary fibrosis (IPF), but most were identified before the use of antifibrotic (AF) therapy in this population. Because pirfenidone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fc0ce4ffbef0a6c3864b1686c5b680
https://escholarship.org/uc/item/0v30q3gr
https://escholarship.org/uc/item/0v30q3gr
Autor:
M.J. Teuber, P. Sathe, K.A. Ramirez, Brooks Kuhn, T. Tham, Maya Juarez, Amir A. Zeki, Willis S. Bowman, Nicholas J. Kenyon, A. Bowlsby, Cameron H. Flayer, Angela Franciska Haczku, Lisa M. Franzi, Angela L. Linderholm, H.N. Saeger, Michael Schivo, I.G. Redai
Publikováno v:
B63. EXPLORING COPD BY MARKER, MECHANISM, AND SIGNATURES.
Autor:
Brooks Kuhn, M.J. Teuber, Amir A. Zeki, Willis S. Bowman, Angela L. Linderholm, A. Bowlsby, P. Sathe, Cameron H. Flayer, Lisa M. Franzi, Michael Schivo, Nicholas J. Kenyon, Angela Franciska Haczku, K.A. Ramirez, H.N. Saeger, Maya Juarez, I.G. Redai
Publikováno v:
C21. ADVANCES IN ADULT AND PEDIATRIC ASTHMA PHENOTYPING AND ENDOTYPING.
Autor:
Angela L. Linderholm, T. Tham, M.J. Teuber, Brooks Kuhn, Willis S. Bowman, Amir A. Zeki, Cameron H. Flayer, Nicholas J. Kenyon, Michael Schivo, P. Sathe, I.G. Redai, Angela Franciska Haczku, H.N. Saeger, Maya Juarez, K.A. Ramirez, A. Bowlsby
Publikováno v:
C61. ASTHMA: CLINICAL STUDIES.
Autor:
Angela L. Linderholm, M.J. Teuber, Maya Juarez, Willis S. Bowman, A. Bowlsby, Angela Franciska Haczku, I.G. Redai, Cameron H. Flayer, T. Tham, Justin M. Oldham, K. Ramirez Barbosa, P. Sathe, Brooks Kuhn, Amir A. Zeki, Lisa M. Franzi, Nicholas J. Kenyon
Publikováno v:
B63. EXPLORING COPD BY MARKER, MECHANISM, AND SIGNATURES.
Autor:
Nam Dao, Felix Chua, Hasan Seede, Philip L. Molyneaux, Gabrielle A. Echt, Willis S. Bowman, Justin M. Oldham, Toby M. Maher, James Tonkin, Mary E. Strek, Chad A. Newton, Ayodeji Adegunsoye, Janelle Vu Pugashetti, Christine Kim Garcia, Cathryn Lee, Zhe Wu
Publikováno v:
Eur Respir J
BackgroundProposed criteria for progressive fibrosing interstitial lung disease (PF-ILD) have been linked to increased mortality risk, but lung function trajectory after satisfying individual criteria remains unknown. Because survival is rarely emplo